XtalPi Holdings (HKSE:02228) Total Equity: HK$10,494.1 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

HKSE:02228 XtalPi Holdings Ltd HKSE:02228
9 GF Score
Price HK$6.84
! 7 Warning Signs
View Full Analysis

What is XtalPi Holdings Total Equity?

XtalPi Holdings HKSE:02228 -5.07% 9 Total Equity is HK$10,494.1 Mil as of Jun. 2026. GuruFocus rates HKSE:02228 with a GF Score™ of 9/100. The stock has 7 warning signs investors should review.

XtalPi Holdings's total equity for the quarter that ended in Jun. 2026 was HK$10,494.1 Mil.

This is Residual interest, including minority interest, that remains in the assets of the enterprise after deducting its liabilities. Equity is increased by owners’ investments and by comprehensive income, and it is reduced by distributions to the owners.

XtalPi Holdings Total Equity Historical Data

* Premium members only.

The historical data trend for XtalPi Holdings's Total Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

XtalPi Holdings Total Equity Chart

XtalPi Holdings Annual Data
Trend Dec21 Dec22 Dec23 Dec24 Dec25
Total Equity
-4,412.94 -5,929.52 -7,920.32 4,262.48 10,418.50

XtalPi Holdings Semi-Annual Data
Dec21 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25 Jun26
Total Equity Get a 7-Day Free Trial Premium Member Only 4,458.54 4,262.48 7,682.75 10,418.50 10,494.06
HKSE:02228
9GF Score
XtalPi Holdings Ltd HKSE:02228
Total Equity is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

XtalPi Holdings Total Equity Calculation

Total Equity and Total Liabilities are the two components for Total Assets.

XtalPi Holdings's Total Equity for the fiscal year that ended in Dec. 2025 is calculated as

Total Equity=Total Assets(Q: Dec. 2025 )-Total Liabilities(Q: Dec. 2025 )
=11287.487-868.988
=10,418.5

XtalPi Holdings's Total Equity for the quarter that ended in Jun. 2026 is calculated as

Total Equity=Total Assets(Q: Jun. 2026 )-Total Liabilities(Q: Jun. 2026 )
=14601.76-4107.702
=10,494.1

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Equity →
What does a Total Equity of HK$10,494.1 Mil mean?
XtalPi Holdings (HKSE:02228) has a Total Equity of HK$10,494.1 Mil as of Jun. 2026. The total amount of equity as record on a company's balance sheet. View historical data for XtalPi Holdings and its competitors.
Is XtalPi Holdings' Total Equity too high?
XtalPi Holdings' current Total Equity is HK$10,494.1 Mil. Overall, XtalPi Holdings has a GF Score™ of 9/100, reflecting its overall financial health beyond just this single metric.
How does XtalPi Holdings' Total Equity compare to VEEV and BTSG?
XtalPi Holdings' Total Equity of HK$10,494.1 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Equity for a Healthcare Providers & Services company?
A good Total Equity depends on the Healthcare Providers & Services industry context. However, Total Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Equity mean?
A high Total Equity can signal that a stock is expensive relative to its fundamentals. The total amount of equity as record on a company's balance sheet. View historical data for XtalPi Holdings and its competitors. XtalPi Holdings's current Total Equity is HK$10,494.1 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is XtalPi Holdings stock overvalued right now?
XtalPi Holdings (HKSE:02228) has a current Total Equity of HK$10,494.1 Mil. The current Total Equity is HK$10,494.1 Mil. XtalPi Holdings' overall GF Score™ is 9/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Equity calculated?
Total Equity is calculated from a company's financial statements. For XtalPi Holdings (HKSE:02228), the current Total Equity is HK$10,494.1 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

XtalPi Holdings Business Description

Other Exchanges V0I:Germany
Address No. 2 Hongliu Road, 3rd floor, Second Phase of the International, Biomedical Industrial Park, Futian District, Shenzhen, CHN
XtalPi Holdings Ltd is a research platform company powered by artificial intelligence (AI) and robotics. It is dedicated to driving intelligent and digital transformation in the life sciences and materials sciences sectors. The company combines quantum physics, AI, cloud computing, and large-scale robotics to provide research & development solutions, services, and products for pharmaceuticals, biotechnology, renewable energy, and materials industries globally. The company has a single segment that is intelligent robotics solutions and drug discovery solutions (including one-stop drug discovery solutions). The firm generates the majority of its revenue from Drug discovery solutions, and a smaller portion of revenue is derived from AI for Science intelligent solutions.
9GF Score

Get the complete analysis for HKSE:02228

Total Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

HK$6.84
Price